We are live on
!
Find out more
iBio
IBIO
IBIO
53 hedge funds and large institutions have $7.63M invested in iBio in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
27% more call options, than puts
Call options by funds: $154K | Put options by funds: $121K
0.01% less ownership
Funds ownership: 0.04% → 0.03% (-0.01%)
24% less funds holding
Funds holding: 70 → 53 (-17)
50% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 18
56% less capital invested
Capital invested by funds: $17.5M → $7.63M (-$9.87M)
59% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 27
Holders
53
Holders Change
-17
Holders Change %
-24.29%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
9
Reduced
18
Closed
27
Calls
$154K
Puts
$121K
Net Calls
+$33K
Net Calls Change
-$1K
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.39M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$547K |
| 3 |
E
Ergoteles
New York
|
+$309K |
| 4 |
Renaissance Technologies
New York
|
+$215K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$150K |
Top Sellers
| 1 |
BlackRock
New York
|
-$3.39M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.12M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$475K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$425K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$360K |
